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Background: Higher intake of dietary fiber is associated with lower risk of coronary heart disease, the leading cause
of mortality among people with type 1 diabetes. The protective effect includes the anti-inflammatory properties of
some foods. Population-based studies have shown an inverse association between some nutritional habits and high
sensitive -C-reactive protein (hs-CRP). This study aimed to ascertain the association between fiber intake and hs-CPR
levels in patients with type 1 diabetes.
Methods: This cross-sectional study was conducted with 106 outpatients with type 1 diabetes; age 40 ± 11 years;
diabetes duration of 18 ± 8.8 years. Dietary intake was evaluated by 3-day weighed-diet records. Patients were
categorized in 2 groups, according to fiber intake (>20 g/day and <20 g/day).
Results: The group with fiber intake > 20 g/day had lower hs-CRP levels [median (25th-75th) 0.7 mg/dl (0.4-2.4) vs. 1.9
mg/dl (1.0-4.4); P = 0.002], than the other group. Controlled for HbA1c and energy intake, an inverse relation was
observed between hs-CRP levels and total fiber [ß = − 0.030 (SE: 0.0120), P = 0.02], soluble fiber [ß = − 0.078 (SE: 0.0421),
P = 0.06] and insoluble fiber [ß = − 0.039 (SE: 0.01761), P = 0.026]. Even, after additional adjustment fibers remained
associated with lower hs-CRP levels. Total fibers were stratified in 4 groups: < 10 g/day, from 10 to < 20 g/day, from 20
to 30 g/day and > 30 g/day. Compared to the group who ingested < 10 g/day of total fiber (referent group), the
group who consumed > 30 g/d had significantly lower hs-CRP levels [−2.45 mg/L, P = 0.012] independent of the
HbA1c values.
Conclusions: The present study suggests that an increased consumption of dietary fiber > 30 g/day may play a
role in reducing inflammation in individuals with type 1 diabetes.
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The consumption of dietary fiber, a group of polysaccha-
rides and lignins of plant origin, has been associated
with a lower risk of coronary heart disease (CHD) [1,2],
the leading cause of mortality among people with type 1
diabetes (T1D) [3]. Epidemiologic studies have consist-
ently shown that greater fruits and vegetables intakes are
associated with a lower risk of incident cardiovascular
events [4,5]. Individuals that consumed more than 5 fruits
and vegetables servings/day had a 26% reduction in risk of
stroke [6] and a 17% reduction in risk of coronary heart* Correspondence: ticianacr@yahoo.com.br
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unless otherwise stated.disease [7] compared with those consuming less than
3 servings/day. A prospective cohort study with 71,706
Swedish participants showed that fruit and vegetables
consumption < 5 servings/day is associated with pro-
gressively shorter survival and higher mortality rates.
They performed a dose–response analysis to evaluate
10th survival percentile differences (PDs) by using Laplace
regression and estimated HRs by using Cox regression.
Those who never consumed fruit and vegetables lived
3 years shorter (PD: −37 months [95% CI −58, −16 mo])
and had a 53% higher mortality rate (HR 1.53 [95% CI
1.19, − 1.99]) than did those who consumed 5 servings
fruit and vegetables/day. Regarding fruit and vegeta-
bles separately, the study showed that those who never
consumed fruit lived 19 months shorter (PD: −19 months
[95% CI −29, −10 mo]) than did those who 1 fruit /day. Par-
ticipants who consumed 3 vegetables/day lived 32 monthsl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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(PD: 32 mo [95% CI 13, 51 mo]) [8]. Potential mechanisms
for the protective effect of this class of food include its anti-
inflammatory properties. Some population-based studies
have shown an inverse association between nutrition and
high sensitive -C-reactive protein (hs-CRP), a marker of
systemic inflammation [9-11]. The high flavonoids fruit
and vegetables diet increased endothelium-dependent
microvascular reactivity (P = 0.017) with +2 portions/
day (at 6 week over habitual intake) and reduced hs-
CRP (P = 0.001) [12].
Particularly, a prudent dietary pattern characterized by
high intakes of vegetables, fruit, and whole grains has
shown to be related to lower concentrations of circulat-
ing CRP [13,14].
In type 2 diabetes (T2D) individuals, the intake of
soluble fibers, mostly from whole-grain foods and
fruits, had a protective role for the presence of MS
[15]. Further, among women with T2D, intakes of
whole grains, bran and cereal fiber were associated with
lower levels of CRP [16].
It’s also well known that patients with diabetes have a
chronic, low-grade inflammatory status [17], and it has
been speculated that this low-grade systemic inflamma-
tion might be implicated in the pathogenesis of not only
insulin resistance and the MS [18], but also of micro-
vascular complications [19,20] and cardiovascular dis-
ease [19-21] in T1D.
Few studies have addressed the role of nutrition in in-
dividuals with T1D [22-24]. In men with T1D, increased
saturated fat intake and lower intake of cereal fiber pre-
dicted a higher waist circumference (WC), whereas a
lower polyunsaturated fat intake and a lower glycemic
index of the diet determined lower WC [22].
Therefore, the main aims of this study were to de-
scribe the nutritional profile of a sample of subjects with
T1D, stratified by fiber intake status, and to ascertain




This cross-sectional study was conducted on a sample of
patients with type 1 diabetes recruited consecutively
from the outpatient endocrinology clinic of Hospital de
Clínicas de Porto Alegre, a large teaching hospital in
Porto Alegre, Brazil. Type 1 diabetes was defined as on-
set before 40 years of age, presence of ketonuria or keto-
nemia at the time of diagnosis, and dependence on
insulin therapy to sustain life. Patients were selected on
the basis of the following criteria: no dietary counseling
by a registered dietitian during the 6 months preceding
study enrollment, age >18 years, and duration of dia-
betes >5 years. Patients with renal failure, symptomaticheart failure (NYHA class III or IV), acute cardiovascu-
lar events in the preceding 6 months (stroke, myocardial
infarction, or acute pulmonary edema), or inability to
complete weighed dietary records were excluded from
the sample. All current medications were continued, ex-
cept for statins. Patients with hs-CRP levels ≥10 mg/L as
measured by a high-sensitivity assay were also excluded,
due to the possibility of other inflammatory conditions.
The recruitment process occurred from January 2011
to December 2011, and all participants provided written
informed consent for participation. The study was con-
ducted according to the guidelines laid down in the
Declaration of Helsinki and the study protocol was ap-
proved by the Hospital de Clínicas de Porto Alegre re-
search ethics committee.Clinical evaluation
All patients were questioned by a physician as to past
medical history, current lifestyle, demographic data, and
current medications. Subjects self-identified as white or
nonwhite (mixed or black) and were classified as current
smokers or noncurrent smokers. Current alcohol intake
was categorized simply as present or absent depending
on whether participants consumed any type of alcoholic
beverage. The frequency of exercise, according to activ-
ities carried out during a typical day, was graded into
four levels on the basis of a standardized questionnaire
as described previously [25]. Level 1 was considered in-
dicative of a sedentary lifestyle.
Sitting blood pressure was measured twice after a 10-min
rest, in the left arm, using a digital sphygmomanometer
(Omron® HEM-705 CP). Hypertension was defined as
blood pressure ≥140/90 mmHg on two separate occa-
sions or use of antihypertensive drugs [26]. All patients
underwent a full physical examination.
Regarding nephropathy, patients were classified accord-
ing to the results of a random spot urine sample or 24-h
timed urine collection (at least two samples obtained
6 months apart). Patients were considered normoalbumi-
nuric when the urinary albumin excretion rate (UAE)
was < 17 mg/L or < 20 μg/min; microalbuminuric when
the UAE was 17–174 mg/L or 20–199 μg/min; and macroal-
buminuric when the UAE was > 176 mg/L or > 199 μg/min
on at least two occasions in a 6-month period [27].
All patients were assessed for diabetic retinopathy (DR)
by an ophthalmologist. DR was detected or evaluated by di-
lated direct and indirect ophthalmoscopy, and the severity
was classified using the Global Diabetic Retinopathy Group
scale [28], as ‘absence of DR’, ‘mild non-proliferative DR’
(NPDR), ‘moderate NPDR’, ‘severe DR’, or ‘proliferative DR’
(PDR). For purposes of analysis, patients were allocated into
two groups (absence of DR or presence of DR regardless of
severity).
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glucose disposal rate (eGDR) published previously [29].
Nutritional evaluation
Body weight (to the nearest 100 g) and height (to the
nearest 0.1 cm) were measured, with subjects barefoot
and wearing lightweight clothing, using a column scale
with height rod (Filizola®, Filizola Balanças Industriais S.
A. Brazil). The body mass index (BMI) (kg/m2) was then
calculated. Waist circumference was measured midway
between the lower rib margin and the iliac crest, near
the umbilicus, using flexible, non-stretch fiberglass tape.
Participants’ usual diets were assessed, by means of 3-day
weighed dietary records (two nonconsecutive weekdays and
one weekend day, with approximately 7 days apart between
each weighted), one time, as previously standardized [30].
Subjects were issued commercially available scales (meas-
urement range, 1–2000 g; CUORI®/CE-cuo-840, Italy) and
measuring cups (25–250 mL; Marinex®, Brazil) and given
detailed explanations and demonstrations of their use. Sub-
jects were considered adherent when the ratio of protein
intake estimated by weighed dietary records to protein in-
take estimated by nitrogen output (protein intake-weighed
dietary records/protein intake-nitrogen ratio) was between
0.79 and 1.26 [31]. Completeness of urine collection was
confirmed by 24-h urinary creatinine measurements.
The nutrient content of dietary records was analyzed
using the Nutribase 2007 Clinical Nutritional Manager
software version 7.14 (Cybersoft, Phoenix, AZ., USA)
and updates [32]. Data were collected from January 2011
to December 2011. Data intakes from nutrients were
expressed as a percentage of total daily energy (%), in
crude amounts (g.day–1), and g/kg weight. Nutrient data
on frequently consumed foods were updated if necessary
and/or supplemented with data obtained from local
manufacturers of specific industrialized foods.
The total, soluble and insoluble fiber content was esti-
mated according to data provided in the CRC Handbook
of Dietary Fiber in Human Nutrition [33]. To analyze the
consumption of fiber according to origin, foods were clas-
sified as whole-grain (included both intact and pulverized
forms), beans and legumes, fruits, tubers (potatoes, sweet
potatoes, cassava and yams), and vegetables. We stratified
the vegetables according to their carbohydrate content (%)
of crude weight: vegetables from group A (5%) and from
group B (10%). The following ingredients in the database
were considered whole grains: whole wheat and whole
wheat flour, whole oats and whole oat flour, whole corn-
meal and whole corn flour, brown rice, whole rye and
whole rye flour, whole barley and bulgur [34].
Laboratory methods
The UAE rate was measured by immunoturbidimetry
(MicroAlb Sera-Pak® immuno microalbuminuria; Bayer,Tarrytown, NY, on Cobas Mira Plus [Roche®]; mean
intra-assay and interassay coefficients of variation, 4.5
and 7.6% respectively). HbA1c levels were measured by
high-performance liquid chromatography (Merck-Hitachi
9100; Merck®, Darmstadt, Germany) (reference range
4.7–6.0%). Fasting plasma glucose was measured by the
glucose-peroxidase colorimetric enzymatic method (Bio-
diagnostica®). Serum creatinine was measured by the Jaffe
method, serum total cholesterol and triglycerides enzym-
atic colorimetric methods (ADVIA® 1800 AutoAnalyzer,
Germany), and HDL cholesterol, by the homogeneous dir-
ect method (ADVIA® 1800 AutoAnalyzer, Germany). LDL
cholesterol was calculated using the Friedewald formula
[35]. hs-CRP was quantitated by turbidimetry (ADVIA®
1800 AutoAnalyzer, Germany), and fibrinogen was deter-
mined by the Clauss clotting method, which measures the
rate of fibrinogen conversion to fibrin in a diluted sample
under the influence of excess thrombin. Urinary urea was
measured by an enzymatic ultraviolet assay (ADVIA® 1800
AutoAnalyzer, Germany).
Statistical analysis
Data are presented as mean ± SD, frequency (%) or me-
dian (IQR). Baseline characteristics were compared by
fiber intake status using Student’s t test, the Mann–
Whitney U test or the chi-square (χ2) test. Pearson correl-
ation was used to describe the correlation between hs-CRP
(log transformed) and other variables. Hotelling t-test was
used to compare correlations among the variables.
To determine the relationship between hs-CRP levels
and fiber intake, we constructed a generalized linear
model (with gamma regression) with hs-CRP levels as
the dependent variable and fiber intake, glycemic con-
trol, age, sex, insulin dose, smoking, and intake of other
nutrients as predictor variables.
All analyses were carried out in SPSS 18.0 (Chicago, IL).
Results
Of 137 consecutive eligible patients, six refused to par-
ticipate in the study, 14 had hs-CRP levels above 10 mg/L,
and eleven were excluded due to compliance issues
(inability to complete dietary records). Thus, 106 pa-
tients were included. The laboratory and clinical char-
acteristics of the excluded group were not different
from the subjects included in the study. Mean age was
40 ± 11 years, and mean duration of diabetes was 18 ±
8.8 years. Overall, 52.8% of subjects (n = 56) were men,
most subjects were white (85.9%, n = 91), and nearly all
were noncurrent smokers (91.5%, n = 97).
Table 1 shows key clinical and laboratory characteris-
tics of patients stratified by median total fiber intake.
Subjects in the higher fiber intake group (>20 g/d) were
more likely to be male (71.2%), were less frequently sed-
entary (34.6%), used lower insulin doses (0.6 ± 0.2 UI/kg
Table 1 Clinical and laboratory profile of subjects with type 1 diabetes, stratified by median total fiber intake
< 20 g/d ≥ 20 g/d P
n 54 52
Age (years) 39.1 ± 11.6 40.9 ± 10.5 0.426†
Caucasian (%) 92.6 78.8 0.117‡
Male (%) 35.2 71.2 <0.001‡
Diabetes duration (years) 18.2 ± 9.5 17.8 ± 8.1 0.378†
Current smoking (%) 13.0 3.8 0.092‡
Frequency of exercise: level 1* (%) 61.1 34.6 0.028‡
Current alcohol intake (%) 44.4 42.3 0.824‡
BMI (kg/m2) 24.3 ± 3.6 24.5 ± 3.4 0.549†
Waist circumference (cm)
Female 78.9 ± 9.2 81.0 ± 8.6 0.448†
Male 84.7 ± 8.4 86.0 ± 9.6 0.607†
Insulin (UI/kg) 0.8 ± 0.3 0.6 ± 0.2 0.012†
Office systolic blood pressure (mmHg) 125.1 ± 15.0 124.6 ± 17.6 0.867†
Office diastolic blood pressure (mmHg) 75.4 ± 11.7 74.3 ± 9.6 0.610†
Hypertension (%) 46.3 32.7 0.152‡
Presence of nephropathy (%) 16.7 11.5 0.449‡
Presence of diabetic retinopathy (%) 44.4 32.7 0.214‡
Fasting plasma glucose (mg/dl) 197.7 ± 132.0 200.2 ± 109.7 0.915†
HbA1c test (%) 9.1 ± 2.1 9.0 ± 1.9 0.752†
Total cholesterol (mg/dl) 190.4 ± 32.5 185.1 ± 36.7 0.434†
HDL cholesterol (mg/dl)
Female 66.1 ± 14.9 69.1 ± 15.5 0.542†
Male 50.3 ± 10.2 53.4 ± 13.7 0.354†
LDL cholesterol (mg/dl) 112.0 ± 26.3 111.7 ± 38.6 0.959†
Triglycerides (mg/dl) 82.0 (59.8-114.2) 79.5 (57.8-114.8) 0.799†
hs-CRP (mg/L) 1.9 (1.0-4.4) 0.7 (0.4-2.4) 0.002†
Fibrinogen (mg/dl) 361.0 (311.5-448.0) 349.0 (271.0-410.0) 0.062†
UAEr (mg/24-h) 7.9 (0.0-21.9) 6.0 (0.0-12.0) 0.604†
Serum creatinine (mg/dl) 0.9 ± 0.4 0.9 ± 0.3 0.721†
eGDR (mg. kg– 1. min– 1) 7.76 ± 2.04 7.58 ± 2.59 0.700†
Data expressed as means ± SD, median (IQR), or n (%). *Level 1 = sedentary.
hs-CRP, high-sensitivity C-reative protein; UAE, urinary albumin excretion rate; eGDR equation glucose disposal rate. † Student’s t test; ‡ chi-square test.
Bernaud et al. Diabetology & Metabolic Syndrome 2014, 6:66 Page 4 of 10
http://www.dmsjournal.com/content/6/1/66vs. 0.8 ± 0.3 UI/kg, P = 0.012), and had lower hs-CRP
levels (median [IQR], 1.9 mg/dl [1.0-4.4] vs. 0.7 mg/dl
[0.4-2.4]; P = 0.002) than those in the low fiber intake
(<20 g/d) group. There were no significant differences in
proportion of white subjects, current smoking, alcohol
intake, presence of hypertension, blood pressure levels,
BMI, waist circumference or presence of microvascular
complications. Plasma glucose, HbA1c, and total, LDL and
HDL cholesterol levels were similar in the two groups.
Regarding daily nutrient intake, the group who con-
sumed >20 g/d of fiber exhibited significantly higher total
energy intake (kcal/d and kcal/weight) and higher carbo-
hydrate and protein intake (crude and g/kg weight) thansubjects who consumed up to 20 g/d fiber. There was a
borderline difference in total energy intake from saturated
fatty acids, and no differences in the percentage of total
energy from protein, carbohydrates and fat (% energy). In-
dividuals who ingested <20 g fiber/d consumed more sat-
urated fat than those with higher fiber intake (10.4 ± 2.7%
vs. 9.3 ± 3.5%, P = 0.059). There were no differences re-
lated to fiber intake status in total energy from saturated
and monounsaturated fatty acids, even when both fatty
acid types were regarded as a single category.
The mean daily intake of nutrients and total fibers
from certain foods, stratified by median total fiber in-
take, is described in Table 2.
Table 2 Daily intake of nutrients among subjects with
type 1 diabetes, stratified by median total fiber intake
< 20 g/d ≥ 20 g/d P
n 54 52
Energy (kcal/day) 1842.1 ± 558.7 2376.4 ± 628.7 < 0.001†
Energy (kcal/weight)/day 28.6 ± 8.0 33.0 ± 8.4 0.006†
Carbohydrates
Crude intake (g) 220.0 ± 66.1 302.1 ± 88.0 < 0.001†
Weight (g/kg) 3.4 ± 1.0 4.2 ± 1.3 < 0.001†
Energy (%) 48.4 ± 8.0 51.4 ± 8.6 0.074†
Protein
Crude intake (g) 82.6 ± 31.5 108.3 ± 35.3 < 0.001†
Weight (g/kg) 1.3 ± 0.5 1.5 ± 0.4 0.007†
Energy (%) 18.0 ± 3.7 18.3 ± 3.4 0.616†
Total fat
Crude intake (g) 70.0 ± 31.6 82.4 ± 35.3 0.011†
Weight (g/kg) 1.1 ± 0.4 1.1 ± 0.5 0.394†
Energy (%) 33.6 ± 8.8 30.7 ± 9.6 0.110†
Saturated fatty acid
Crude intake (g) 22.1 ± 10.4 24.5 ± 10.8 0.247†
Weight (g/kg) 0.3 ± 0.1 0.3 ± 0.1 0.952†
Energy (%) 10.4 ± 2.7 9.3 ± 3.5 0.059†
Monounsaturated fatty acid
Crude intake (g) 24.6 ± 11.6 28.4 ± 12.7 0.107†
Weight (g/kg) 0.4 ± 0.2 0.4 ± 0.2 0.530†
Energy (%) 11.7 ± 3.5 10.6 ± 3.4 0.098†
Polyunsaturated fatty acid
Crude intake (g) 11.6 (8.3-19.9) 18.4 (10.6-26.0) 0.026§
Weight (g/kg) 0.2 (0.1-0.3) 0.2 (0.1-0.3) 0.148§
Energy (%) 6.0 (4.2-10.0) 7.1 (4.6-0.4) 0.733§
Trans fatty acid –
crude intake (g)
0.1 (0.0-0.3) 0.1 (0.0-0.4) 0.069§
Cholesterol (mg) 239.9 ± 148.4 239.0 ± 116.3 0.972†
Total fiber (g)
Crude intake (g) 14.6 ± 3.5 27.2 ± 6.8 < 0.001†
Weight (g/kg) 0.2 ± 0.1 0.4 ± 0.1 < 0.001†
Soluble fiber
Crude intake (g) 4.3 ± 1.3 7.8 ± 2.1 < 0.001†
Weight (g/kg) 0.1 ± 0.0 0.1 ± 0.0 < 0.001†
Insoluble
Crude intake (g) 10.5 ± 2.8 19.4 ± 5.1 < 0.001†
Weight (g/kg) 0.2 ± 0.1 0.3 ± 0.1 < 0.001†
Fibers from fruits
Total fiber (g) 1.4 (0.2-2.7) 3.0 (1.4-4.9) 0.005§
Fibers from vegetables (A + B)
Total fiber (g) 1.1 (0.5-2.5) 2.8 (1.5-4.0) 0.001§
Table 2 Daily intake of nutrients among subjects with
type 1 diabetes, stratified by median total fiber intake
(Continued)
Fibers from Tuberous
Total fiber (g) 0.4 (0.0-0.76) 0.2 (0.0-0.8) 0.062§
Fibers from whole-grain
foods
Total fiber (g) 0.4 (0.0-3.8) 1.1 (0.0-4.5) 0.104§
Fibers from legumes
and beans
Total fiber (g) 2.5 (0.1-6.7) 8.4 (5.5-12.7) < 0.001§
Data expressed as means ± SD or median (IQR).
† Student’s t test; § Mann–Whitney U test.
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sumed more fiber from fruit, A and B vegetables, le-
gumes, and beans than subjects in the low-fiber group.
To determine the relationship between fiber intake
and hs-CRP levels, additional analyses were performed.
First, to understand other variables possibly involved
with inflammatory status, correlations between hs-CRP
levels (log-transformed) and others variable were calcu-
lated. The hs-CRP level correlated with HbA1c (r = 0.29,
P = 0.002), eGDR (r = −0.286, P = 0.003), total energy intake
(kcal/day and kcal/weight) (r = −0.26, P = 0.008; r = −0.31,
P = 0.001, respectively), protein intake (crude and g/kg)
(r = − 0.34, P = 0.001; r = −0.39, P <0.001), and carbohy-
drate intake (crude and g/kg) (r =−0.26, P = 0.007; r = −0.28,
P = 0.004), as well as with total dietary fiber intake
(crude and g/kg) (r = −0.30, P = 0.002; r = −0.33, P < 0.001),
soluble fiber intake (crude and g/kg) (r = −0.24, P = 0.012;
r = −0.27, P = 0.005) and insoluble fiber intake (crude
and g/kg) (r = −0.30, P = 0.002; r = −0.33, P = 0.001). In
this sample, fatty acid intake did not correlate with hs-
CRP levels.
Hotelling t-test was used to compare correlations
among the variables, we observed that there is an effect
of the protein on the correlation between hs-CRP and
fiber intake, as well there is an effect of the fiber on the
correlation between the protein intake and hs-CRP. The
partial squared correlation coefficients for fiber, protein
and carbohydrates in models adjusting for age, sex,
HbA1c, smoking and insulin dose was 0.26, 0.29 and
0.30 respectively for carbohydrates, proteins and fibers.
In a regression linear model with the hs-CRP as
dependent variable and age, sex, HbA1c, smoking, insu-
lin dose, energy (kcal/day) and fiber intake as independ-
ent variables, the fiber remained associated with hs-CRP
levels independent of the adjustment of the others vari-
ables. However, when the fiber was replaced by protein
or carbohydrates intake, with the same adjusts, protein
and carbohydrates were not associated with the hs-CRP.
When, the stratification for fiber (below and above of
the median), adjusted for age, sex, HbA1c, smoking and
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The fiber > 20 g/day was associated with the hs-CRP levels
(beta = − 0.281, p = 0.005).
The regression coefficients of dietary total fiber, sol-
uble fiber and insoluble fiber for predicting hs-CRP
levels from a generalized linear model are shown in
Table 3. The results of analyses unadjusted and adjusted
for covariates are presented. After controlling for HbA1c
and energy intake, a significant inverse correlation was
observed between hs-CRP levels and total, soluble and
insoluble fiber intake. After adjusting for HbA1c and
protein or carbohydrate intake, total, soluble and insol-
uble fiber intake remained inversely associated with
lower hs-CRP levels. Notably, HbA1c also remained as-
sociated with hs-CRP levels in all models constructed,
including sex, smoking and physical activity.
On the basis of these results, and to examine potential
differences between the amount of fiber intake and
HbA1c levels in relation to hs-CRP concentrations, we
constructed models with total fiber intake stratified into
four groups (<10 g/day, from 10 to < 20 g/day, 20–30 g/day
and >30 g/day) and adjusted for HbA1c (stratified into
tertiles). The regression coefficients of these variables
for predicting hs-CRP from a generalized linear model
are presented in Table 4. Compared to the group who
ingested < 10 g/day total fiber (referent group), subjects
who consumed >30 g/day had significantly lower hs-
CRP levels (−2.45 mg/L, P = 0.012) regardless of HbA1c
values. Furthermore, as compared with the lowest
HbA1c tertile (the referent group), subjects in the highest
tertile had higher hs-CRP levels (1.387 mg/L, P = 0.006)
regardless of fiber intake.
We also examined the associations between total, sol-
uble and insoluble fiber intake and HbA1c with hs-CRP
levels stratified into tertiles (0.0–0.72 mg/L, 0.721–
2.81 mg/L and 2.811–10 mg/L), as illustrated in Figure 1.
Subjects with hs-CRP levels in the second and last ter-
tiles had significantly lower total fiber and soluble fiber
intake (Figure 1-A and B) when compared with individ-
uals in the first hs-CRP tertile (those with the lowest
hs-CRP levels). No difference in intake was observed
between the second and third tertiles. Subjects in the
highest hs-CRP tertile consumed less insoluble fiberTable 3 Regression coefficients (beta, ß) of dietary total, solu
according to a generalized linear model
Unadjusted Adjusted
ß (SE) P ß (SE)
Total fiber (g/day) −0.039 (0.0118) 0.001 −0.030 (0.0120)
Soluble fiber (g/day) −0.106 (0.0417) 0.011 −0.078 (0.0421)
Insoluble fiber (g/day) - 0.053 (0.0160) 0.001 −0.039 (0.0176)
1Adjusted for HbA1c and energy intake (kcal/weight).
2Adjusted for HbA1c and weight (g/kg) of protein.
3Adjusted for HbA1c and weight (g/kg) of carbohydrate.than subjects in the first tertile (Figure 1-C). We also
observed that subjects with hs-CRP levels in the third
tertile had higher HbA1c levels than those in the sec-
ond and first hs-CRP tertiles (Figure 1-D). There was
no difference in HbA1c levels between subjects in the
second and first hs-CRP tertiles.
Discussion
The present study showed an inverse association be-
tween serum hs-CRP levels and intake of dietary fiber
(total, soluble and insoluble fiber) in persons with T1D.
Subjects who consumed higher amounts of dietary fiber
had lower hs-CRP levels. After adjusting for possible
confounders, this association persisted for all types of
dietary fiber intake. Total dietary fiber intake in excess
of 20 g/day was associated with even lower levels of hs-
CRP. Notably, the level of total dietary fiber intake
(>30 g/day) found to be associated with lower hs-CRP
levels in this study was not different from that recom-
mended for the general population and for persons with
diabetes by the American Diabetes Association (14 g/
1000 kcal) [36].
In the study sample, the median total dietary fiber in-
take was 20 g/day. The main sources of dietary fiber in
the >20 g/day group were fruits, vegetables (A + B), le-
gumes and beans. A prospective study evaluated the as-
sociation between quantity and variety of fruit and
vegetable intake and incidence of T2D [37]. Their results
suggested that a greater combined fruit and vegetable in-
take was associated with a 21% lower risk of T2D (HR
0.79 [95% CI 0.62-1.00]) on comparison of extreme tertiles
(highest tertile = 3.4 [2.9-4.4] servings/day and lowest ter-
tile = 0.6 [0.3-0.9] servings/day), in adjusted analyses tak-
ing variety into account. When the authors compared
extreme tertiles of fruit variety (6.9 ± 1.2 vs. 2.0 ± 1.0
items/week), vegetable (11.4 ± 1.5 vs. 5.5 ± 1.4) and com-
bined fruit and vegetable intake (16.3 ± 8.0 vs. 8.0 ± 1.8), a
greater variety in these intakes was associated with lower
risks of T2D (30%, 22% and 39% respectively).
The protective role of foods rich in soluble fibers has
been previously evaluated in T2D patients with MS [15].
Total fiber and soluble fiber intake from whole-grain
foods and fruits were negatively associated with MS. Theble and insoluble fiber for prediction of hs-CRP levels
1 Adjusted2 Adjusted3
P ß (SE) P ß (SE) P
0.02 −0.037 (0.0140) 0.007 −0.042 (0.0134) 0.002
0.06 −0.092 (0.0426) 0.03 −0.098 (0.0426) 0.022
0.026 −0.050 (0.0194) 0.009 −0.057 (0.0184) 0.002
Table 4 Regression coefficients (beta, ß) of different
amounts of dietary total fiber and HbA1c tertiles for




<10 g/day - -
10 - < 20 g/day −0.507 (0.8407) 0.546
20 - 30 g/day −0.986 (0.8562) 0.250
>30 g/day −2.450 (0.9744) 0.012
HbA1c
Tertile 1 - -
Tertile 2 0.186 (0.4992) 0.709
Tertile 3 1.37 (0.5041) 0.006
SE, standard error. HbA1c tertiles: 6.3–8.0%, 8.01–9.3%, and > 9.3%.
Bernaud et al. Diabetology & Metabolic Syndrome 2014, 6:66 Page 7 of 10
http://www.dmsjournal.com/content/6/1/66mean daily intake of total fiber (20.3 ± 7.8 g/day) of pa-
tients without MS in that study was similar to the me-
dian (IQR) (20.0 [14.9-25.5]) of daily total fiber intake
in our study of T1D patients. Data from the EURO-
DIAB Complications Study [22], a cross-sectional investi-
gation of T1D patients, also reported a mean total fiber
intake of 20.0 g/day and a percentage of energy intake
from protein of 17.4%, both of which are similar to our
findings. The total fat intake observed in the European
study (percentage of energy from fat, 37.9%) was higher
than that observed in our study, regardless of fiber in-
take status (33.6% in the < 20 g fiber/day group vs.
30.7% in the >20 g fiber/day group). This difference is
explained by higher intake of monounsaturated and satu-
rated fats. A similar finding was also reported in a U.S.
population of persons with T1D [23], i.e. a higher percent-
age of energy from saturated fat as compared with that
found in our sample (12.9% vs. 10.4%). Our patients had
higher carbohydrate intake than that observed in both of
the above-cited studies: percentage of energy from carbo-
hydrates, 48.4% vs. 41.9% [22] and 44% [23]. These data
demonstrate the lack of literature on fiber intake in T1D
populations.
The association between high fruit and vegetable intake
and a lower risk of mortality from ischemic heart disease
(IHD) was demonstrated in the European Prospective
Investigation into Cancer and Nutrition (EPIC)-Heart
Study [38], where subjects who ate at least eight serv-
ings (80 g each) of fruits and vegetables per day had a
22% lower risk of fatal IHD compared with those who
consumed fewer than three portions a day.
The role of inflammation in the etiology of several
chronic diseases—perhaps the most notable being cardio-
vascular disease (CVD), diabetes and several types of
cancer—is supported by epidemiological evidence [39-41].
CRP levels consistently predict positive associations with
chronic conditions, including malignant disease [42-45].Although several studies have examined associations
between dietary fiber intake and serum hs-CRP levels
[16,46-48] there are no available data in the literature
about the effects of dietary fiber on systemic inflamma-
tion in populations with T1D. Our findings are consist-
ent with those of previous observational and clinical
intervention studies that investigated the relationship be-
tween dietary fiber intake and serum hs-CRP levels
[16,46,48,49] in the general population. In our sample,
subjects with T1D who consumed >30 g/day of total
fiber had lower levels of hs-CRP (−2.450 mg/L) than
those who ingested <10 g/day.
Ma et al. [49], using cross-sectional and longitudinal
data from 524 healthy adult participants of the Sea-
sonal Variation of Blood Cholesterol Levels Study
(SEASONS), reported an inverse association between
intake of total dietary fiber (separately for soluble and
insoluble fiber) and hs-CRP concentrations. The coeffi-
cient for the cross-sectional effect of dietary total fiber
was −0.01, and −0.02 for insoluble dietary fiber, ad-
justed for covariates. Our findings for the effect were
somewhat higher: −0.042 for total fiber, −0.098 for sol-
uble fiber, and −0.057 for insoluble fiber. When we
stratified total fiber intake, this effect was even greater
in the >30 g fiber/day group. This may be attributable
to differences in the characteristics of the studied
population, and the effect of fiber in persons with T1D
may be greater than in non-diabetic individuals.
Using cross-sectional data from the general popula-
tion, Ajani et al. reported that the odds ratio (OR) of ele-
vated hs-CRP levels was 0.49 (95% CI: 0.37-0.65) for the
highest quintile of total fiber intake (32 g/day) as com-
pared with the lowest quintile (5.1 g/day) [46].
In a multiethnic cohort of early-stage breast cancer sur-
vivors, Villaseñor et al. [47] investigated the relationship
between intake of total, soluble, and insoluble dietary fiber
and hs-CRP levels. Inverse associations were found be-
tween total fiber intake (ß = −0.029; 95% CI −0.049, −0.008;
P = 0.006), insoluble fiber intake (ß = −0.039; 95%
CI −0.064, −0.013; P = 0.003) and hs-CRP levels. When
only hs-CRP levels ≥3 mg/L and tertiles of total, soluble
and insoluble dietary fiber intake were taken into ac-
count, the association held only for the highest tertile
of insoluble fiber intake (mean intake, 15.5 ± 3.4 g/day).
de Mello et al. observed that, after 3 months of a diet-
ary intervention consisting of an experimental diet high
in fatty fish, bilberries and wholegrain products (Healthy
Diet) or a whole-grain-enriched (WGED) diet, subjects
with impaired glucose metabolism and features of MS
had lower hs-CRP levels than controls assigned to a
low-fiber diet. The authors also observed that both inter-
vention diets (Healthy and WGED) were associated with
a reduction in 2-hour plasma glucose levels as compared
with the control diet (mean ± SD: 120.7 ± 30.6 mg/dL vs.
Figure 1 Unadjusted mean total fiber intake (A), soluble fiber intake (B), insoluble fiber intake (C) and HbA1c% (D) by hs-CRP tertiles
(mg/L) in 106 subjects with type 1 diabetes. hs-CRP levels stratified into tertiles (first: 0.0–0.72 mg/L; second: 0.721–2.81 mg/L; third: 2.811–
10 mg/L).* different from the first tertile and ** different from the third tertile with P < 0.001.
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34.2 mg/dL respectively) [50]. HbA1c levels were not
reported.
However, not all randomized clinical trials support the
beneficial role of fiber, at least from wholegrains, in in-
flammation or cardiovascular risk factors. The Women’s
Health Initiative Dietary Modification Trial [51], a ran-
domized controlled trial including more than 48,000
postmenopausal women and followed for 8 year, showed
an increased risk of 1.26 [95% CI 1.03 - 1.54] for CVD
in those women with cardiovascular disease CVD at
baseline and allocated to the intervention arm. The
intervention consisted in a low-fat diet with more than
6 servings/day of wholegrains, and 5 servings/day of
fruits and vegetables. Lefevre et al. concluded that epi-
demiological studies provide reasonable support for anassociation between diets high in whole grains and
lower CRP concentrations. After adjusting for other
dietary factors, each serving of whole grains is esti-
mated to reduce CRP concentrations by approximately
7%. Nonetheless, interventional studies do not demon-
strate a clear effect of increased whole-grain consump-
tion on CRP or other markers of inflammation [52].
The cross-sectional nature of this study precludes
evaluation of causality due to the uncertain temporality
of associations. Nevertheless, this design allowed us to
assess the usual diet of T1D patients. The high average
HbA1c levels found in this sample are also a potential
limitation. However, the cohort enrolled in this study
was composed of unselected adults with T1D treated
routinely at an outpatient endocrinology clinic and can
thus be considered representative of real patients outside
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ter study conducted in different regions of Brazil [53].
In conclusion, the results of the current study show
that a higher consumption of dietary fiber is associated
with lower hs-CRP levels in persons with T1D. High
dietary fiber intake (>30 g/day) may play a role in redu-
cing inflammation in this population. Randomized con-
trolled trials of high- and low-fiber diets are required to
support public health recommendations.
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